PLoS ONE (Jan 2024)

Cognitive function in pituitary adenoma patients: A cross-sectional study.

  • David Krabbe,
  • Katharina S Sunnerhagen,
  • Daniel S Olsson,
  • Tobias Hallén,
  • Oskar Ragnarsson,
  • Thomas Skoglund,
  • Gudmundur Johannsson

DOI
https://doi.org/10.1371/journal.pone.0309586
Journal volume & issue
Vol. 19, no. 9
p. e0309586

Abstract

Read online

Various factors may affect cognition in patients with pituitary adenoma, including size and extension of the tumor, degree of pituitary hormone deficiencies, and treatment of the tumor, most often being transsphenoidal surgery (TSS). The aim of this cross-sectional study was to evaluate cognitive function in patients with clinically significant pituitary adenoma and to identify factors influencing cognition. Sixty-eight patients with pituitary adenoma were included. Of these, 31 patients were evaluated before TSS and 37 patients 12 months following TSS. Cognitive function was evaluated by using the Repeatable Battery for the Assessment of Neuropsychological Status. Patients had lower mean scores on cognitive assessment compared to age-adjusted normative data. Variability in cognition, analyzed by linear regression analysis, was explained by sex, educational level, and self-perceived fatigue, but not by pituitary hormone deficiencies, diabetes insipidus, or surgical treatment. Our results are in line with previous findings, namely that pituitary adenoma affects cognition. To better evaluate the factors affecting cognition, longitudinal studies are recommended. Such studies would allow for within-individual comparisons, effectively controlling for the considerable influence of sex and education on test results.